REFERENCES
- Bunn, F., Alderson, P., Hawkins, V. (2001). Colloid solutions for fluid resuscitation. Cochrane Database Syst. Rev. CD001319, , [CSA]
- Alderson, P., , et al. (2004). Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst. Rev. CD001208, , [CSA]
- Roberts, I., , et al. (2004). Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst. Rev. CD000567, , [CSA]
- Ernest, D., Belzberg, A.S., Dodek, P.M. (1999). Distribution of normal saline and 5% albumin infusions in septic patients. Crit. Care Med. 27: 46–50, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Roberts, J.S., Bratton, S.L. (1998). Colloid volume expanders. Problems, pitfalls and possibilities. Drugs 55: 621–630, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lieberthal, W., , et al. (2002). Comparison of the effects of a 50% exchange-transfusion with albumin, hetastarch, and modified hemoglobin solutions. Shock 17: 61–69, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lieberthal, W. , et al. (1999). O-raffinose cross-linking markedly reduces systemic and renal vasoconstrictor effects of unmodified human hemoglobin. J. Pharmacol. Exp. Ther. 288: 1278–1287, [PUBMED], [INFOTRIEVE], [CSA]
- Adamson, J.G., Moore, C. (1998). Hemolink, an o-raffinose crosslinked hemoglobin-based oxygen carrier, in Blood Substitutes: Principles, Methods, Products and Clinical Trials, T.M.S. Chang, Ed., Karger Landes: New York.
- Gawryl, M., Clark, T., Rausch, C. (1991). Characterization of highly purified polymerized bovine hemoglobin, in Red Cell Substitutes: The Proceedings of the Second International Symposium of Red Cell Substitutes, S. Sekuguchi, Ed., Kindai Shuppan: Tokyo.
- Lieberthal, W., Fuhro, R., Andry, C., Valeri, C. R. (2000). Effects of hemoglobin-based oxygen-carrying solutions in anesthetized rats with acute ischemic renal failure. J. Lab. Clin. Med. 135: 73–81, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Thompson, A., Valeri, C.R., Lieberthal, W. (1995). Endothelin receptor A blockade alters hemodynamic response to nitric oxide inhibition in rats. Am. J. Physiol. 269: H743–H748, [PUBMED], [INFOTRIEVE], [CSA]
- Lieberthal, W., Thompson, A., Valeri, C.R. (1996). Effects of nitric oxide inhibition on systemic and renal hemodynamics in the hemorrhaged rat. Kidney Blood Press Res. 19: 340–346, [PUBMED], [INFOTRIEVE], [CSA]
- Thompson, A., McGarry, A.E., Valeri, C.R., Lieberthal, W. (1994). Stroma-free hemoglobin increases blood pressure and GFR in the hypotensive rat: role of nitric oxide. J. Appl. Physiol. 77: 2348–2354, [PUBMED], [INFOTRIEVE], [CSA]
- Creteur, J., Vincent, J.L. (2003). Hemoglobin solutions. Crit Care Med 31: S698–S707, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kingma, J.G., Jr., , et al. (2002). The effects of hemodilution with Hemolink upon hemodynamics and blood flow distribution in anesthetized dogs. Artif. Cells Blood Substit. Immobil. Biotechnol. 30: 137–154, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Levy, J.H., , et al. (2002). Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. J. Thorac. Cardiovasc. Surg. 124: 35–42, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Moqattash, S., Lutton, J.D., Rosenthal, G., Abu-Hijleh, M.F., Abraham, N.G. (1997). Effect of blood substitute, recombinant hemoglobin, on in vivo hematopoietic recovery from AZT toxicity. Acta. Haematol. 98: 76–82, [PUBMED], [INFOTRIEVE], [CSA]
- Cheng, D.C. (2001). Safety and efficacy of o-raffinose cross-linked human hemoglobin (Hemolink) in cardiac surgery. Can. J. Anaesth. 48: S41–S48, [PUBMED], [INFOTRIEVE], [CSA]
- Lamy, M.L., , et al. (2000). Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. The DCLHb Cardiac Surgery Trial Collaborative Group. Anesthesiology 92: 646–656, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sloan, E.P., , et al. (1999). Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: A randomized controlled efficacy trial JAMA. 282: 1857–1864, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kerner, T., , et al. (2003). DCL-Hb for trauma patients with severe hemorrhagic shock: the European “On-Scene” multicenter study. Intensive Care Med. 29: 378–385, [PUBMED], [INFOTRIEVE], [CSA]
- Swan, S.K., , et al. (1995). Pharmacologic profile of diaspirin cross-linked hemoglobin in hemodialysis patients. Am. J. Kidney Dis. 26: 918–923, [PUBMED], [INFOTRIEVE], [CSA]